News & Media
THE ZOOMING EYE LENS: Effects of Age on Dynamic Range of Focus
DYNAMIC RANGE OF FOCUS (DRoF), or the total range of clear vision in a natural system, is an important biomechanical function of the accommodative apparatus responsible for adjusting the crystalline lens from both far to near (accommodation) and near to far (disaccommodation). DRoF is defined by true accommodation, pseudoaccommodation, and pupillary diaphragmatic changes, which work together …
read moreIN-OFFICE SURGICAL PROCEDURES FOR PRESBYOPIA
In-office procedures offer ophthalmic surgeons and patients the greatest flexibility and efficiency of scheduling. Procedures such as YAG capsulotomy, select laser trabeculoplasty, laser pupil iridoplasty, LASIK/PRK/SMILE and minor lid procedures are routinely done within the in-office surgery suite. A large 2016 study demonstrated the safety and outcomes of cataract procedures performed within the surgeon’s office, …
read moreDr. Robert Ang in CRST
What other future treatments have promise? Laser scleral microporation is under investigation as a laser treatment for patients with emmetropic presbyopia. Four quadrants of the sclera are treated with an Er:YAG laser to uncrosslink the sclera and rejuvenate the accommodative mechanism (see video demonstration below). Treatment does not appear to affect the visual axis or …
read moreLaser scleral microporation improves near vision in emmetropic presbyopes
WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Robert E. Ang, MD, discusses results from a study of laser scleral microporation.
read morePathogenesis of Presbyopia: A New Understanding of an Age-Old Disease
FOR MOST OF HISTORY, PRESBYOPIA has been defined as a “normal” refractive error caused by age, with discussion limited to the loss of near vision beginning in our 40s. Because we have had no effective therapeutic interventions available, presbyopia has been accepted as a natural part of life and treated primarily by changing power at either …
read moreThe Future of the Aging Eye
AnnMarie Hipsley, the Founder and CEO of Ace Vision Group (AVG), a Delaware, USA- based company developing innovative therapeutics for age-related ocular dysfunctions, talks to The Ophthalmologist about her background and work with AVG, and the company’s short- and long-term goals. She explains how the Group has utilized artificial intelligence and virtual reality platforms to …
Show video